New Edge Advisors, LLC Cooper Companies, Inc. Transaction History

New Edge Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$306.88 - $380.0 $38,973 - $48,260	127 New	127 $48,000
Q4 2022 Feb 14, 2023	BUY	$248.67 - $334.17 $20,390 - $27,401	82 New	82 $27,000
Q3 2019 Nov 06, 2019	SELL	$294.25 - $341.49 $354,277 - $411,153	-1,204 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$279.29 - $336.89 $24,298 - $29,309	87 Added 7.79%	1,204 $406,000
Q1 2019 May 14, 2019	SELL	$246.18 - $297.25 $2.74 Million - $3.31 Million	-11,148 Reduced 90.89%	1,117 $331,000
Q1 2019 May 09, 2019	BUY	$246.18 - $297.25 $2.79 Million - $3.37 Million	11,329 Added 1210.36%	12,265 $702,000
Q4 2018 Jan 29, 2019	BUY	$232.7 - $281.66 $18,616 - $22,532	80 Added 9.35%	936 $238,000
Q3 2018 Oct 29, 2018	BUY	$236.3 - $277.15 $1,890 - $2,217	8 Added 0.94%	856 $237,000
Q2 2018 Jul 19, 2018	BUY	$217.98 - $237.23 $184,847 - $201,171	848 New	848 $200,000
Q3 2017 Nov 13, 2017	SELL	$231.6 - $253.39 $106,767 - $116,812	-461 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	461	461 $0

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.